Modulation of renal calcium handling by 11β-hydroxysteroid dehydrogenase type 2

Journal of the American Society of Nephrology

Volumn 13, Issue 10, 2002, Pages 2540-2546

  Ferrari, Paolo ^a   Bianchetti, Mario G ^a   Sansonnens, Aurelie ^a   Frey, Felix J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CALCIUM ION; CREATININE; GLYCYRRHETINIC ACID; MINERALOCORTICOID RECEPTOR; POTASSIUM; SODIUM;

ADULT; ARTICLE; CALCIUM EXCRETION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY METABOLISM; KIDNEY TUBULE ABSORPTION; MALE; NORMAL HUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM EXCRETION; URINARY EXCRETION;

EID: 0036785158     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000028640.78526.0F     Document Type: Article

References (47)

1. Krozowski ZS, Funder JW: Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80: 6056-6060, 1983
2. Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988
3. Agarwal AK, Monder C, Eckstein B, White PC: Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 264: 18939-18943, 1989
4. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS: Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105: R11-R17, 1994
5. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK: Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80: 2203-2209, 1995
6. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC: Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet 10: 394-399, 1995
7. Ferrari P, Obeyesekere VR, Li K, Wilson RC, New MI, Funder JW, Krozowski ZS: Point mutations abolish 11β-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. Mol Cell Endocrinol 119: 21-24, 1996
8. Wilson RC, Dave-Sharma S, Wei JQ, Obeyesekere VR, Li K, Ferrari P, Krozowski ZS, Shackleton CH, Bradlow L, Wiens T, New MI: A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci USA 95: 10200-10205, 1998
9. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New MI: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49: 757-764, 1979
10. Moudgil A, Rodich G, Jordan SC, Kamil ES: Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome. Pediatr Nephrol 15: 60-62, 2000
11. Resnick LM, Laragh JH, Sealey JE, Alderman MH: Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med 309: 888-891, 1983
12. Martell-Claros N, Fernandez-Pinilla C, de la Quadra F, Herrero E, Ruiz D, Fernandez-Cruz A, Luque-Otero M: Calcium intake, calcium excretion and blood pressure in adolescents in the upper decile of the distribution: The Torrejon study. J Hypertens Suppl 7: S256-S257, 1989
13. Resnick LM, Laragh JH: Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 78: 385-390, 1985
14. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C: Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 8: 884-893, 1995
15. Massry SG, Coburn JW, Chapman LW, Kleeman CR: The acute effect of adrenal steroids on the interrelationship between the renal excretion of sodium, calcium, and magnesium. J Lab Clin Med 70: 563-570, 1967
16. Reid IR, Ibbertson HK: Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Horm Res 27: 200-204, 1987
17. Bostanjoglo M, Reeves WB, Reilly RF, Velazquez H, Robertson N, Litwack G, Morsing P, Dorup J, Bachmann S, Ellison DH, Bostonjoglo M: 11β-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J Am Soc Nephrol 9: 1347-1358, 1998
18. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I,Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP: Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24-30, 1996
19. Karet FE, Lifton RP: Mutations contributing to human blood pressure variation. Recent Prog Horm Res 52: 263-276, 1997
20. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CR: Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 125:1046-1053, 1989
21. Whorwood CB, Sheppard MC, Stewart PM: Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 132: 2287-2292, 1993
22. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR: Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821-824, 1987
23. Ferrari P, Sansonnens A, Dick B, Frey FJ: In vivo 11βHSD-2 activity: Variability, salt-sensitivity, and effect of licorice. Hypertension 38: 1330-1336, 2001
24. Vannini SD, Mazzola BL, Rodoni L, Truttmann AC, Wermuth B, Bianchetti MG, Ferrari P: Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine. Transpl Int 12: 244-249, 1999
25. Nordin BE, Hodgkinson A, Peacock M: The measurement and the meaning of urinary calcium. Clin Orthop 52: 293-322, 1967
26. Shackleton CH: Mass spectrometry in the diagnosis of steroidrelated disorders and in hypertension research. J Steroid Biochem Mol Biol 45: 127-140, 1993
27. Suki WN, Schwettmann RS, Rector FC, Jr., Seldin DW: Effect of chronic mineralocorticoid administration on calcium excretion in the rat. Am J Physiol 215: 71-74, 1968
28. Cappuccio FP, Markandu ND, MacGregor GA: Renal handling of calcium and phosphate during mineralocorticoid administration in normal subjects. Nephron 48: 280-283, 1988
29. Rastegar A, Agus Z, Connor TB, Goldberg M: Renal handling of calcium and phosphate during mineralocorticoid "escape" in man. Kidney Int 2: 279-286, 1972
30. Friedman PA: Codependence of renal calcium and sodium transport. Annu Rev Physiol 60: 179-197, 1998
31. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP: Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13: 183-188, 1996
32. Stahl MM, Vaara I: Gitelman versus classic Bartter syndrome. J Pediatr 123: 671-672, 1993
33. Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P: Renal calcifications: A complication of long-term furosemide therapy in preterm infants. Pediatrics 70: 360-363, 1982
34. Gehr MK, Goldberg M: Hypercalciuria of mineralocorticoid escape: Clearance and micropuncture studies in the rat. Am J Physiol 251: F879-F888, 1986
35. Biner HL, Arpin-Bott MP, Loffing J, Wang X, Knepper M, Hebert SC, Kaissling B: Human cortical distal nephron: Distribution of electrolyte and water transport pathways. J Am Soc Nephrol 13: 836-847, 2002
36. Velazquez H, Naray-Fejes-Toth A, Silva T, Andujar E, Reilly RF, Desir GV, Ellison DH: Rabbit distal convoluted tubule coexpresses NaCl cotransporter and 11β-hydroxysteroid dehydrogenase II mRNA. Kidney Int 54: 464-472, 1998
37. Hoenderop JG, van der Kemp AW, Hartog A, van de Graaf SF, van Os CH, Willems PH, Bindels RJ: Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 274: 8375-8378, 1999
38. Peng JB, Chen XZ, Berger UV, Vassilev PM, Brown EM, Hediger MA: A rat kidney-specific calcium transporter in the distal nephron. J Biol Chem 275: 28186-28194, 2000
39. Loffing J, Loffing-Cueni D, Valderrabano V, Klausli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B: Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 281: F1021-F1027, 2001
40. Leppla D, Browne R, Hill K, Pak CY: Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts. J Clin Endocrinol Metab 57: 920-924, 1983
41. Bourdeau JE, Hellstrom-Stein RJ: Voltage-dependent calcium movement across the cortical collecting duct. Am J Physiol 242: F285-F292, 1982
42. Burg MB, Issaacson L, Grantham J, Orloff J: Electrical properties of isolated perfused rabbit renal tubules. Am J Physiol 215: 788-794, 1968
43. Hanley MJ, Kokko JP, Gross JB, Jacobson HR: Electrophysiologic study of the cortical collecting tubule of the rabbit. Kidney Int 17: 74-81, 1980
44. O'Neil RG, Helman SI: Transport characteristics of renal collecting tubules: Influences of DOCA and diet. Am J Physiol 233: F544-F558, 1977
45. Brands MW, Hall JE: Renal perfusion pressure is an important determinant of sodium and calcium excretion in DOC-salt hypertension. Am J Hypertens 11: 1199-1207, 1998
46. Lemann J Jr, Pleuss JA, Gray RW, Hoffmann RG: Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults. Kidney Int 39: 973-983, 1991
47. Krishna GG, Chusid P, Hoeldtke RD: Mild potassium depletion provokes renal sodium retention. J Lab Clin Med 109: 724-730, 1987